Table 2.

Initial response to therapy and response at follow-up in the study group.

Initial Response to Therapy	n (%)
Excellent	1116 (83.1%)
Indeterminate	160 (11.9%)
Biochemical incomplete	32 (2.4%)
Structural incomplete	35 (2.6%)
Final Follow-Up	n (%)
NED	1226 (91.3%)
Indeterminate	69 (5.2%)
Biochemical incomplete	14 (1.1%)
Structural incomplete	33 (2.4%)
Follow-Up: Recurrence after NED	n (%)
No	1106 (82.3%)
Yes	10 (0.7%)
Death	n (%)
No	1445 (98.6%)
TC-unrelated	6 (0.4%)
TC-related	15 (1.0%)
Median Follow-Up Time, Years (Range)	5.0 (0.0–40.0)

NED, no evidence of disease; TC, thyroid cancer.